Lundi, 16 Septembre 2019
Dernières nouvelles
Principale » The Frank Medici Sells 131800 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

The Frank Medici Sells 131800 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

19 Juillet 2017

The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The Director now owns $377,005,804 of the stock per the Form 4 SEC filing.

On Friday, July 14th, Berkley Capital, Llc sold 72,791 shares of HealthEquity stock. The shares were sold at an average price of $51.41, for a total transaction of $3,742,185.31. The shares were sold at an average price of $51.79, for a total value of $2,903,709.93.

On Wednesday, June 21st, Frank Medici sold 154,265 shares of HealthEquity stock. Director Frank Medici sold 537,102 shares at a price of $51.32 on Friday the 14th. The stock was sold at an average price of $50.27, for a total value of $1,188,835.23.

On Tuesday, June 20th, Berkley Capital, Llc sold 21,000 shares of HealthEquity stock. The shares were sold at an average price of $51.94, for a total transaction of $8,012,524.10.

On Tuesday, June 13th, Berkley Capital, Llc sold 248,351 shares of HealthEquity stock. The shares were sold at an average price of $52.80, for a total value of $13,112,932.80. HealthEquity, Inc. has a 12-month low of $27.45 and a 12-month high of $54.95. (NASDAQ HQY) traded down 0.84% on Friday, reaching $50.96. 237,137 shares of the stock traded hands.

HealthEquity, Inc.'s P/E ratio is 95.79 and market capitalization is 3.06B. The firm's 50-day moving average price is $48.61 and its 200-day moving average price is $45.03.

North Korea says to take "corresponding measures" if United Nations adopts sanctions
As per the data of General Administration of Customs of China, the country exported more than $ 3,00,000 in May this year. Kim called the missile's July 4 launch test a "gift" to the "American bastards" as the US celebrated Independence Day.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, June 6th. As of the last earnings report the EPS was $0.53 and is expected to be $0.58 for the current year with 59,973,000 shares now outstanding. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. The business had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. During the same quarter in the prior year, the company earned $0.15 EPS. The business's quarterly revenue was up 25.9% compared to the same quarter past year. Oppenheimer Holdings, Inc. reaffirmed an "outperform" rating and issued a $61.00 price objective (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th.

Shares of HealthEquity, Inc.

On Wednesday, June 14th, Frank Medici sold 210,906 shares of HealthEquity stock. If you are viewing this story on another site, it was illegally stolen and reposted in violation of worldwide copyright and trademark legislation. The correct version of this story can be viewed at https://baseballnewssource.com/markets/healthequity-inc-nasdaqhqy-major-shareholder-berkley-capital-llc-sells-72791-shares-of-stock/1216221.html.

A number of research firms have recently weighed in on HQY. Zacks Investment Research raised shares of HealthEquity from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research report on Wednesday. Cantor Fitzgerald upped their price target on HealthEquity from $55.00 to $56.00 and gave the company an "overweight" rating in a research report on Wednesday, July 5th. Chardan Capital restated a "buy" rating and issued a $53.00 price target (up from $50.00) on shares of HealthEquity in a report on Wednesday, March 22nd. Finally, J P Morgan Chase & Co boosted their price target on HealthEquity from $44.00 to $51.00 and gave the company an "overweight" rating in a report on Wednesday, March 22nd. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. The company now has an average rating of "Buy" and an average target price of $50.22.

A number of institutional investors have recently modified their holdings of HQY. Dimensional Fund Advisors LP raised its stake in shares of HealthEquity by 18.9% in the fourth quarter. Following the completion of the transaction, the director now owns 6,381 shares in the company, valued at approximately $326,962.44. The value of the total investment in HealthEquity, Inc. went from $5,000 to $3,000 a change of $2,000 quarter to quarter. State Street Corp raised its stake in shares of HealthEquity by 7.3% in the fourth quarter. Putnam Investments LLC now owns 33,387 shares of the company's stock valued at $1,353,000 after buying an additional 437 shares during the period. Arcadia Investment Management Corp MI increased its stake in HealthEquity by 81.7% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 13,600 shares of the company's stock valued at $551,000 after buying an additional 1,600 shares during the period. Nuveen Asset Management LLC bought a new position in shares of HealthEquity during the first quarter worth approximately $6,387,000. Accern also gave headlines about the company an impact score of 0 out of 100, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days.

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.